Researcher
Piet STINISSEN
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, Inflammation, Genetics, Neurological and neuromuscular diseases
Affiliations
- Limburg Clinical Research Center (Research Center)
Responsible
From1 Sep 2022 → Today - Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Responsible
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From1 Oct 2005 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Jan 1999 → Today - Biomedical Research Institute (Research institute)
Responsible
From1 Oct 2005 → 10 Nov 2009 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From1 Jan 1999 → 30 Sep 2009 - Immunology - Biochemistry (Research group)
Member
From1 Jan 1992 → 31 Dec 2019 - Immunology - Biochemistry (Research group)
Responsible
From1 Jan 1992 → 31 Dec 2019
Projects
1 - 10 of 62
- IOF mandate Limburg Clinical Research Center (LCRC) 2024-2028From1 Jan 2024 → TodayFunding: IOF - mandates
- Structural funding of the LCRC centerFrom1 Jan 2024 → TodayFunding: BOF - research organisations
- Return to work through primary care: The development of a toolkit for general practitionersFrom1 Jan 2024 → TodayFunding: Department of Economy, Science and Innovation
- Donation agreement between Hasselt University, Mylan EPD BV and Noorderhart vzw regarding UMSC.From20 Dec 2022 → 20 Apr 2023Funding: Nonprofit institution or equivalents
- Integrated approach through first-line zones for reintegration into the labor market among the long-term sickFrom19 Dec 2022 → 18 Dec 2023Funding: Department of Economy, Science and Innovation
- Translational MS research UMSC.From29 Sep 2022 → 31 Dec 2022Funding: Industrial enterprises
- Unravelling the mechanism of single time vaccination strategy (SinTimVaS)From21 Feb 2022 → 31 Dec 2022Funding: BOF - projects
- NEURONET - Phase IIIFrom1 Feb 2022 → TodayFunding: BOF - Methusalem
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- DigiPath: The introduction of digital pathology in LimburgFrom16 Dec 2021 → TodayFunding: Provinces, Own budget, for example: patrimony, inscription fees, gifts
Publications
11 - 20 of 158
- Multiple sclerosis associated cytotoxic CD4+T cells escape regulatory T cell mediated suppression(2018)
Authors: Cindy HOEKS, Marjan VANHEUSDEN, Ludo PEETERS, Piet STINISSEN, Bieke BROUX, Niels HELLINGS
Pages: 395 - 396 - Cytotoxic CD4+T Cells Drive Multiple Sclerosis Progression(2017)
Authors: Liesbet PEETERS, Marjan VANHEUSDEN, Veerle SOMERS, Bart VAN WIJMEERSCH, Piet STINISSEN, Bieke BROUX, Niels HELLINGS
Pages: 1 - 7 - Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells(2017)
Authors: Stelios RAVANIDIS, Jeroen BOGIE, Raf DONDERS, Robert Deans, Jerome HENDRIKS, Piet STINISSEN, Jef Pinxteren, Robert W. Mays, Niels HELLINGS
Pages: 1 - 17 - Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation(2017)
Authors: Marjan VANHEUSDEN, Bieke BROUX, Suzanne P. M. Welten, Liesbet PEETERS, Eleni Panagioti, Bart VAN WIJMEERSCH, Veerle SOMERS, Piet STINISSEN, Ramon Arens, Niels HELLINGS
Pages: 1 - 11 - Cytomegalovirus and cytotoxic CD4+ T cells are key players in exacerbation of multiple sclerosis(2017)
Authors: Marjan VANHEUSDEN, Piet STINISSEN
Number of pages: 212 - Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL(2017)
Authors: Winde JORISSEN, Elien WOUTERS, Jeroen BOGIE, Tim VANMIERLO, Jean-Paul NOBEN, Denis Sviridov, Niels HELLINGS, Veerle SOMERS, Roland VALCKE, Bart Vanwijmeersch, et al.
Pages: 1 - 14 - Oncostatin M signaling is essential for robust remyelination(2017)
Authors: Kris JANSSENS, Anurag MAHESHWARI, Chris Vandenhaute, Tom STRUYS, Ivo LAMBRICHTS, Veerle Baekelandt, Piet STINISSEN, Jerome HENDRIKS, Helena Slaets, Niels HELLINGS
Pages: E438 - E438 - Age-Associated B Cells with Proinflammatory Characteristics Are Expanded in a Proportion of Multiple Sclerosis Patients(2016)
Authors: Nele CLAES, Judith FRAUSSEN, Marjan VANHEUSDEN, Niels HELLINGS, Piet STINISSEN, Bart VAN WIJMEERSCH, Raymond Hupperts, Veerle SOMERS
Pages: 4576 - 4583 - B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses(2016)
Authors: Judith FRAUSSEN, Nele CLAES, Bart VAN WIJMEERSCH, Jack VAN HORSSEN, Piet STINISSEN, Raymond Hupperts, Veerle SOMERS
Pages: 124 - 132 - Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis(2016)
Authors: Liesbeth DE WINTER, Wendy HANSEN, Hanna W. Van Steenbergen, Piet GEUSENS, Jan Lenaerts, Klaartje SOMERS, Piet STINISSEN, Annette H.M. Van der Helm-Van Mil, Veerle SOMERS
Pages: 1431 - 1436
Patents
1 - 9 of 9
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- METABOLIC MARKERS FOR DIAGNOSING OF CANCER (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)